
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Bayesian Analysis of Tests with Unknown Specificity and Sensitivity
Andrew Gelman, Bob Carpenter
Journal of the Royal Statistical Society Series C (Applied Statistics) (2020) Vol. 69, Iss. 5, pp. 1269-1283
Open Access | Times Cited: 123
Andrew Gelman, Bob Carpenter
Journal of the Royal Statistical Society Series C (Applied Statistics) (2020) Vol. 69, Iss. 5, pp. 1269-1283
Open Access | Times Cited: 123
Showing 1-25 of 123 citing articles:
Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
Sophie Uyoga, Ifedayo Adetifa, Henry Karanja, et al.
Science (2020) Vol. 371, Iss. 6524, pp. 79-82
Open Access | Times Cited: 313
Sophie Uyoga, Ifedayo Adetifa, Henry Karanja, et al.
Science (2020) Vol. 371, Iss. 6524, pp. 79-82
Open Access | Times Cited: 313
Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
Xinhua Chen, Zhiyuan Chen, Andrew S. Azman, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 5, pp. e598-e609
Open Access | Times Cited: 239
Xinhua Chen, Zhiyuan Chen, Andrew S. Azman, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 5, pp. e598-e609
Open Access | Times Cited: 239
Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis
Niklas Bobrovitz, Rahul K. Arora, Christian Cao, et al.
PLoS ONE (2021) Vol. 16, Iss. 6, pp. e0252617-e0252617
Open Access | Times Cited: 239
Niklas Bobrovitz, Rahul K. Arora, Christian Cao, et al.
PLoS ONE (2021) Vol. 16, Iss. 6, pp. e0252617-e0252617
Open Access | Times Cited: 239
Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications
Andrew Levin, Nana Owusu‐Boaitey, Sierra Pugh, et al.
BMJ Global Health (2022) Vol. 7, Iss. 5, pp. e008477-e008477
Open Access | Times Cited: 162
Andrew Levin, Nana Owusu‐Boaitey, Sierra Pugh, et al.
BMJ Global Health (2022) Vol. 7, Iss. 5, pp. e008477-e008477
Open Access | Times Cited: 162
Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study
Jason Rosado, Stéphane Pelleau, Charlotte Cockram, et al.
The Lancet Microbe (2020) Vol. 2, Iss. 2, pp. e60-e69
Open Access | Times Cited: 107
Jason Rosado, Stéphane Pelleau, Charlotte Cockram, et al.
The Lancet Microbe (2020) Vol. 2, Iss. 2, pp. e60-e69
Open Access | Times Cited: 107
Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial
Boris Revollo, Ignacio Blanco, Pablo Soler, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 10, pp. 1365-1372
Open Access | Times Cited: 92
Boris Revollo, Ignacio Blanco, Pablo Soler, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 10, pp. 1365-1372
Open Access | Times Cited: 92
Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys
Daniel B. Larremore, Bailey K. Fosdick, Kate M. Bubar, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 89
Daniel B. Larremore, Bailey K. Fosdick, Kate M. Bubar, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 89
Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance
Stéphane Le Vu, Gabrielle Jones, François Anna, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 85
Stéphane Le Vu, Gabrielle Jones, François Anna, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 85
Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya
Ifedayo Adetifa, Sophie Uyoga, John N. Gitonga, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 55
Ifedayo Adetifa, Sophie Uyoga, John N. Gitonga, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 55
Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada
Danuta M. Skowronski, Samantha E Kaweski, Michael A. Irvine, et al.
Canadian Medical Association Journal (2022) Vol. 194, Iss. 47, pp. E1599-E1609
Open Access | Times Cited: 45
Danuta M. Skowronski, Samantha E Kaweski, Michael A. Irvine, et al.
Canadian Medical Association Journal (2022) Vol. 194, Iss. 47, pp. E1599-E1609
Open Access | Times Cited: 45
Estimating the COVID-19 infection fatality ratio accounting for seroreversion using statistical modelling
Nicholas F. Brazeau, Robert Verity, Sara Jenks, et al.
Communications Medicine (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 38
Nicholas F. Brazeau, Robert Verity, Sara Jenks, et al.
Communications Medicine (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 38
Seroprevalence of Antibodies to SARS-CoV-2 in Rural Households in Eastern Uganda, 2020-2022
Jessica Briggs, Saki Takahashi, Patience Nayebare, et al.
JAMA Network Open (2023) Vol. 6, Iss. 2, pp. e2255978-e2255978
Open Access | Times Cited: 23
Jessica Briggs, Saki Takahashi, Patience Nayebare, et al.
JAMA Network Open (2023) Vol. 6, Iss. 2, pp. e2255978-e2255978
Open Access | Times Cited: 23
Bayesian workflow for disease transmission modeling in Stan
Léo Grinsztajn, Elizaveta Semenova, Charles C. Margossian, et al.
Statistics in Medicine (2021) Vol. 40, Iss. 27, pp. 6209-6234
Open Access | Times Cited: 52
Léo Grinsztajn, Elizaveta Semenova, Charles C. Margossian, et al.
Statistics in Medicine (2021) Vol. 40, Iss. 27, pp. 6209-6234
Open Access | Times Cited: 52
SARS-CoV-2 seroprevalence in Germany
Daniela Gornyk, Manuela Harries, Stephan Glöckner, et al.
Deutsches Ärzteblatt international (2021)
Open Access | Times Cited: 44
Daniela Gornyk, Manuela Harries, Stephan Glöckner, et al.
Deutsches Ärzteblatt international (2021)
Open Access | Times Cited: 44
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance
Javier Perez‐Saez, María‐Eugenia Zaballa, Sabine Yerly, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 11, pp. 1695.e7-1695.e12
Open Access | Times Cited: 43
Javier Perez‐Saez, María‐Eugenia Zaballa, Sabine Yerly, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 11, pp. 1695.e7-1695.e12
Open Access | Times Cited: 43
Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys
Daniel B. Larremore, Bailey K. Fosdick, Kate M. Bubar, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 45
Daniel B. Larremore, Bailey K. Fosdick, Kate M. Bubar, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 45
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors
Sophie Uyoga, Ifedayo Adetifa, Henry Karanja, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 44
Sophie Uyoga, Ifedayo Adetifa, Henry Karanja, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 44
Serial population-based serosurveys for COVID-19 in two neighbourhoods of Karachi, Pakistan
Muhammad Imran Nisar, Nadia Ansari, Farah Khalid, et al.
International Journal of Infectious Diseases (2021) Vol. 106, pp. 176-182
Open Access | Times Cited: 35
Muhammad Imran Nisar, Nadia Ansari, Farah Khalid, et al.
International Journal of Infectious Diseases (2021) Vol. 106, pp. 176-182
Open Access | Times Cited: 35
Understanding the Challenges and Uncertainties of Seroprevalence Studies for SARS-CoV-2
David J. McConnell, Conor Hickey, Norma Bargary, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 9, pp. 4640-4640
Open Access | Times Cited: 34
David J. McConnell, Conor Hickey, Norma Bargary, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 9, pp. 4640-4640
Open Access | Times Cited: 34
Prevalence of SARS-CoV-2 in urban and rural Ethiopia: Randomized household serosurveys reveal level of spread during the first wave of the pandemic
Saro Abdella, Samuel Riou, Masresha Tessema, et al.
EClinicalMedicine (2021) Vol. 35, pp. 100880-100880
Open Access | Times Cited: 33
Saro Abdella, Samuel Riou, Masresha Tessema, et al.
EClinicalMedicine (2021) Vol. 35, pp. 100880-100880
Open Access | Times Cited: 33
Seroprevalence of anti-SARS-CoV-2 antibodies in Colombia, 2020: A population-based study
Marcela Mercado, Jeadran Malagón-Rojas, Isabel Rodríguez-Barraquer, et al.
The Lancet Regional Health - Americas (2022) Vol. 9, pp. 100195-100195
Open Access | Times Cited: 25
Marcela Mercado, Jeadran Malagón-Rojas, Isabel Rodríguez-Barraquer, et al.
The Lancet Regional Health - Americas (2022) Vol. 9, pp. 100195-100195
Open Access | Times Cited: 25
Mental Health Assessment of the Population: Study Protocol of the MAP Research Program in Ukraine (MAP-U) and in Zurich (MAP-Z)
Viktoriia Yasenok, Eileen Neumann, Alessia Raineri, et al.
International Journal of Public Health (2025) Vol. 69
Open Access
Viktoriia Yasenok, Eileen Neumann, Alessia Raineri, et al.
International Journal of Public Health (2025) Vol. 69
Open Access
Associations between fecal contamination of the household environment and enteric pathogen detection in children living in Maputo, Mozambique
David Holcomb, Jackie Knee, Zaida Adriano, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
David Holcomb, Jackie Knee, Zaida Adriano, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Serological signatures of SARS-CoV-2 infection: Implications for antibody-based diagnostics
Jason Rosado, Stéphane Pelleau, Charlotte Cockram, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 35
Jason Rosado, Stéphane Pelleau, Charlotte Cockram, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 35
High Community SARS-CoV-2 Antibody Seroprevalence in a Ski Resort Community, Blaine County, Idaho, US. Preliminary Results
Colleen C. McLaughlin, Margaret K. Doll, Kathryn Morrison, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 35
Colleen C. McLaughlin, Margaret K. Doll, Kathryn Morrison, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 35